Testosterone therapy is receiving renewed attention, not only from patients but also from regulatory agencies. In recent months, the U.S. Food and Drug Administration (FDA) updated the safety information for testosterone products, reflecting new evidence on cardiovascular risk. This has generated understandable questions among men who are considering therapy and clinicians who prescribe it. As
Testosterone cardiovascular risk: FDA update 2025 originally appeared in KevinMD.com.
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.